Show results for
Refine by
Clinical Screening Trial Services In Germany
30 services found
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Pharmacokinetics (PK) studies provide critical information regarding the behavior of a drug in circulation and its ultimate form after extensive in vivo metabolism. Results from PK studies often serve as guidelines for clinical trials designs, especially in the development of an antibody-drug conjugate (ADC). Due to the heterogeneous nature of ADCs, multiple analytes have to be assessed to reveal ...
by:PharmAI GmbH based inDresden, GERMANY
Increase your success rate at an early stage. With pharmAI's rapid off-target prediction service you can already find potential off-targets during the discovery ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Pharmacokinetics (PK) studies provide critical information regarding the behavior of a drug in circulation and its ultimate form after extensive in vivo metabolism. Results from PK studies often serve as guidelines for clinical trials designs, especially in the development of an antibody-drug conjugate (ADC). Due to the heterogeneous nature of ADCs, multiple analytes have to be assessed to reveal ...
by:Eurofins bioskin ( formely Bioskin GmbH) based inHamburg, GERMANY
bioskin has an extensive network of investigators and partners which enable reliable and fast feasibility, site selection and trial set-up for large multicenter trials. Our flexibility and dedication to detail, coupled with our expertise over the entire field of dermatology, set us apart from other CROs. Our project teams are fine-tuned with members from regulatory affairs, clinical trial ...
by:Vetter based inRavensburg, GERMANY
Our experts provide the guidance, insight, and Vetter process documentation you need to prepare a Common Technical Document (CTD) for clinical trials of your injectable drug ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Prior to clinical trials, it is necessary to conduct animal toxicity studies to best characterize the potential toxicity of new drug candidates. Generally, the objective of preclinical safety evaluation is to determine the toxic effects with respect to target organs, dose dependency, the relationship between clinical findings and exposure to the compound, and potential reversibility of findings. ...
Manufactured by:Immatics N.V. based inTuebingen, GERMANY
Immatics’ latest proprietary ACTengine® manufacturing processes are designed to generate cell product candidates within a short manufacturing window and deliver highly proliferative T cells, with the capability to infiltrate the patient’s tumor and function in a challenging solid tumor microenvironment. Immatics is actively investigating multiple next-generation enhancement ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Drug discovery and development is an attractive strategy for treating various human diseases. In particular, different types of drugs, such as vaccines, antibodies, have been generated and tested in many preclinical and clinical trials. ...
Manufactured by:Immatics N.V. based inTuebingen, GERMANY
Patients eligible for clinical trials with ACTengine® product candidates have a portion of their white blood cells collected using a well-established process called leukapheresis, a procedure in which a fraction of the white blood cells of a patient is extracted from their peripheral blood. These white blood cells are transferred to a manufacturing facility where peripheral blood mononuclear ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Creative Biolabs offers engineered protein scaffold library construction service. Our service has provided a strong foundation for the successful isolation and exploitation of high-affinity binders in the fields of research, diagnosis, and therapy. Creative Biolabs has developed trimer codon technology, which offers site-directed mutant library construction in a high-throughput and extremely ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Antibody characterization is important in research and biopharmaceutical development. All therapeutic proteins produced from current technologies have heterogeneities in the final product because various modifications occur during different stages of production. Due to these heterogeneities, thorough characterization is necessary for the reproducible and safe production of therapeutic ...
Manufactured by:CENTOGENE N.V. based inRostock, GERMANY
We provide a broad range of services to successfully operate clinical trials. We leverage our proprietary Bio/Databank, multiomic platform, extensive physician network and our experts to ensure efficient and effective solutions to drive progress in the rare disease ...
by:Eurofins bioskin ( formely Bioskin GmbH) based inHamburg, GERMANY
The path to approval for generic topical products can be challenging. bioskin can help you to optimally plan and implement a development strategy: Vasoconstrictor assays according to FDA guidance: Bioequivalence of topical corticosteroids in Europe and the USA is assessed using the vasoconstrictor or human skin blanching assay as outlined in the FDA guidance. bioskin offers a competitive package ...
Manufactured by:ProBioGen AG based inBerlin, GERMANY
Biologics have revolutionized the treatment of a number of severe diseases and thus given hope to countless patients. Your aim is to create a biosimilar that has the same properties as a successful biologic but is more affordable and hence available to even more patients. You need the process to be perfectly reliable for outstanding results and fast success. We can take you there. For more than ...
by:Molecular Health GmbH based inHeidelberg, GERMANY
Act beyond human and experimental limitations. Knowledge to advance game-changing therapies from idea to market. The world's biomedical knowledge at your fingertips. Reliable predictions to anticipate risks. Interlinked data to find new targets and design novel drugs. Real-world evidence to evaluate success. These capabilities eliminate the uncertainties that limit drug development but are ...
by:Comjoodoc, by Teamedio GmbH based inBerlin, GERMANY
Our services for hospitals are designed to facilitate smooth cross-organizational, interdisciplinary and intersectoral cooperation. This ensures greater efficiency and quality of care in clinical care and in cooperation with outpatient care providers. With comjoodoc, clinics can implement their digitization strategy and respond perfectly to new conditions. Our customers are: University clinics, ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Expanded Access to our Investigational Medicinal Products Policy. At MorphoSys, our mission is to make innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Before these and all other investigational medicinal products can be made broadly available, the U.S. Food and Drug Administration (FDA) and other health authorities around the world require that ...
by:HAPILA GmbH based inGera, GERMANY
HAPILA GmbH is a company with many years of tradition in the synthesis and development of active ingredients. We have accompanied our partners from the idea on paper to clinical phase III for almost two decades. Some of our long-standing business partners still supply the market with medicines made from HAPILA active ...
by:Indivumed GmbH based inHamburg, GERMANY
Biomarkers are important when it comes to the development of novel drugs and mechanisms and are also gaining importance as companion diagnostic ...
by:Vetter based inRavensburg, GERMANY
Explore how we transform your API into a supply of high-quality clinical material for your ...